Business of the House
May we have an update from a Health Minister on progress in the review of prostate cancer policy and whether it will focus, as it should, on such issues as targeting particularly vulnerable age groups or ethnic groups, such as black males, one quarter of whom will be affected by this disease at some stage in their lives, and speeding up National Institute for Health and Care Excellence approval of relevant drug treatments in England and Wales which are already being prescribed in Northern Ireland and Scotland?